Red Light Therapy, Class IV Lasers, and Pulmonary Fibrosis: Hope or Hype?
Pulmonary fibrosis (PF), particularly idiopathic pulmonary fibrosis (IPF), remains one of the most challenging chronic lung conditions. Characterized by excessive collagen buildup and scarring of the lungs, it leads to progressive breathing difficulties, reduced oxygen exchange, and ultimately respiratory failure. Traditional therapies focus on slowing disease progression with antifibrotic drugs like nintedanib and pirfenidone. But what about complementary approaches like red light therapy (RLT) or laser-based treatments? Could they help, or might they actually do more harm than good?
What Is Red Light Therapy (RLT)?
Red light therapy (also known as low-level laser therapy or photobiomodulation) uses wavelengths of red and near-infrared light (typically 630–900 nm) to stimulate tissue repair, reduce inflammation, and improve circulation.
Devices range from wearable pads to full-body panels (e.g., Hooga panels or red light pads sold on Amazon). Originally studied for skin health and wound healing, RLT has gained popularity for pain relief, muscle recovery, and even anti-aging effects.
Common Uses of RLT:
– Skin health: Enhances collagen production, reduces wrinkles
– Wound healing: Stimulates fibroblast activity
– Pain relief and muscle recovery
– Scar tissue remodeling in superficial tissues
Red Light Therapy and Collagen: A Double-Edged Sword
RLT is well known for its ability to stimulate collagen production by activating fibroblasts and supporting mitochondrial ATP production. This is great for cosmetic uses and tendon healing, but it presents a major concern in PF, where the problem is too much collagen, not too little.
In PF, fibroblasts are overactive, laying down excess collagen that stiffens the lung tissue and reduces its ability to expand and exchange gases.
Stimulating fibroblasts further, even inadvertently, could risk worsening lung scarring if red light reaches the lung tissues. That said, light penetration is typically limited to 1-2 inches through skin and soft tissue, making it unlikely that red light from a home-use device would reach the lungs in a meaningful way. But it’s a theoretical risk.
What About Class IV Lasers?
Class IV lasers are higher-powered devices (over 500 mW) typically used in physical therapy clinics and chiropractic practices. They penetrate deeper than LED panels or Class I-III lasers and can deliver high doses of light energy to deeper tissues.
Common Uses of Class IV Lasers:
– Musculoskeletal pain management
– Sports injuries: to promote faster tissue repair
– Post-surgical healing
– Wound healing-thought to improve circulation
– Inflammatory and autoimmune conditions (limited evidence)
– Veterinary medicine – used for musculoskeletal pain and wound healing
Concerns in PF:
While animal studies have shown that laser therapy may reduce fibrosis-related cytokines (like TGF-β and IL-6), there is no published human trial confirming that Class IV lasers can safely or effectively treat PF. The use of high-powered lasers over the chest area in people with fibrotic lung disease raises both theoretical benefits and potential safety concerns.
Dr. Andy Hall’s Work: A Case for Laser Use in IPF?
Dr. Andy Hall, a chiropractor from California, was diagnosed with IPF in 2014. Facing limited treatment options, he began self-administering Class IV laser therapy to his chest and back. According to his own reports and those of his clinic (Summit Chiropractic & Therapeutic Laser Center), Dr. Hall experienced stabilized lung function, no new fibrosis progression on imaging, and maintained oxygen saturation levels around 97-99%.
Dr. Hall’s Protocol (As Publicly Described):
- Laser Type: Class IV continuous-wave infrared laser (10+ watts)
- Application: 5 minutes over the chest and 5 over the back
- Frequency: 3 times weekly for a month, then weekly maintenance
- Total energy: ~5400 Joules per session
He reports having referred many patients with PF/IPF for similar laser therapy, some of whom have posted anecdotal success stories. However, these are uncontrolled personal experiences and not validated by randomized trials.
Dr. Hall and others in the laser therapy community reference animal studies where red light reduced fibrotic markers, but these studies were in rodents with chemically induced lung fibrosis and used lower-level lasers or LEDs, not Class IV lasers.
What Does the Science Say?
Animal Evidence:
Some mice studies (e.g., using chemically-induced lung fibrosis) suggest low-level laser therapy can reduce fibrosis by suppressing inflammation and collagen deposition.
However, translation to human PF/IPF is speculative or in other words, unproven.
Human Evidence:
There are no human clinical trials demonstrating efficacy of Class IV or red light laser therapy in pulmonary fibrosis.
Current guidelines do not include laser therapy in the standard of care for PF or IPF.
Safety:
Low-level devices (like LED panels or pads) are generally considered safe on the skin and muscles.
High-power lasers over fibrotic lungs may have unknown risks and should only be used under medical supervision or in a clinical trial.
Final Takeaway: Caution and Curiosity
The idea that red or near-infrared light could slow fibrosis or improve symptoms is scientifically intriguing. There is early animal data and anecdotal human experience (notably from Dr. Hall) suggesting potential benefits. But without rigorous human trials, it’s too early to recommend these treatments as safe or effective for PF.
If you have PF and are considering red light or laser therapy:
- Do not apply over the lungs unless part of a clinical trial or under supervision.
- Use for unrelated issues (e.g., back pain) may be fine, but check with your pulmonologist.
- Avoid practitioners promising “cures” without clinical trial backing.
Science is always evolving, and what seems fringe today may become tomorrow’s breakthrough—but only if we stay cautious, curious, and evidence-based.
Join the discussion about alternative and complementary therapies in our community forum and virtual support group meetups.
Leave a comment